SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-087819
Filing Date
2021-06-30
Accepted
2021-06-30 21:22:54
Documents
2
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2121126-9_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2121126-9_3seq1.xml 3 1616
2 EXHIBIT 24 tm2121126d9_ex24.htm EX-24 9303
  Complete submission text file 0001104659-21-087819.txt   12332
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (647) 401-2182
POINT Biopharma Global Inc. (Issuer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address
MARGOLIN YAEL (Reporting) CIK: 0001868637 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39373 | Film No.: 211063691